![]() | Ian S MenziesKing's College School of Medicine and Dentistry, London, UK | King's College School of Medicine and Dentistry, London, United Kingdom | Departments of Child Health and ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
Ian S Menzies:Expert Impact
Concepts for whichIan S Menzieshas direct influence:Intestinal permeability,Cirrhotic patients,Enteral feeding,Coeliac disease,Iron deficiency,Degree relatives,Atopic eczema,Intestinal inflammation.
Ian S Menzies:KOL impact
Concepts related to the work of other authors for whichfor which Ian S Menzies has influence:Intestinal permeability,Cardiopulmonary bypass,Enteral nutrition,Cardiac surgery,Small intestine,Coeliac disease,Liver cirrhosis.
KOL Resume for Ian S Menzies
Year | |
---|---|
2004 | King's College School of Medicine and Dentistry, London, UK |
2000 | King's College School of Medicine and Dentistry, London, United Kingdom |
1999 | Departments of Child Health and Medicine, Kings College Hospital, Denmark Hill, London SE5 9RS St Thomas's Hospital, Lambeth Palace Road, London SE1 7EH, UK. |
1996 | Department of Clinical Pharmacology, University of Newcastle upon Tyne. |
1995 | Department of Medicine, Chelsea and Westminster Hospital, London. |
1994 | Gastrointestinal Laboratory, Rayne Institute, and Dept. of Clinical Chemistry, St Thomas' Hospital, London, UK Dept. of Clinical Biochemistry, King's College School of Medicine and Dentistry, and Dept. of Chemical Pathology, U.M.D.S. Guy's and St Thomas's Hospital, London, United Kingdom Department of Chemical Pathology, St Thomas' Hospital, London, United Kingdon |
1993 | Department of Clinical Biochemistry, Kings College Hospital, London, United Kingdom St Thomas's Hospital, London. UK |
1992 | Department of Pediatrics, Rambam Medical Center, and Technion-Faculty of Medicine, Haifa, Israel, and Department of Chemical Pathology, St. Thomas' Hospital Medical School, London, United Kingdom Section of Gastroenterology, MRC Clinical Research Centre, Harrow, Middlesex. Division of Chemical Pathology, St. Thomas's Hospital Medical School, London, England |
1991 | Section of Gastroenterology, Northwick Park Hospital and MRC Clinical Research Centre, Harrow, Middlesex Dept. of Chemical Pathology, St Thomas Hospital Medical School, London, UK Dept. of Clinical Biochemistry, Kings College School of Medicine and Dentistry, London, UK Gastrointestinal Laboratory, St Thomas's Hospital, London. |
1990 | Department of Chemical Pathology and Metabolic Disorders, St Thomas's Hospital, London. Depts. of Chemical Pathology and Physiology, and Gastrointestinal Laboratory, St Thomas Hospital, London, UK |
1989 | Department of Chemical Pathology, Metabolic Disorders, St. Thomas's Hospital, London, UK Section of Gastroenterology, MRC Clinical Research Centre, Harrow, Middlesex |
1988 | St. Thomas Hospital Medical School, London SW1 |
1986 | Departments of Paediatrics and Chemical Pathology, St Thomas’ Hospital, London SE1 7EH, UK Department of Chemical Pathology and Metabolic Disorders, and the Gastrointestinal Laboratory, U.M.D.S. Guy's and St Thomas's Hospital, London, and Division of Clinical Sciences and Cell Biology, MRC Clinical Research Centre, Northwick Park Hospital, Harrow, Middlesex, U.K. |
1985 | Department of Chemical Pathology and Metabolic Disorders, St. Thomas's Hospital Medical School, London (U.K.) |
1984 | St Thomas' Hospital, London, and MRC Clinical Research Centre, Harrow, Middlesex |
1983 | Department of Chemical Pathology, St Thomas' Hospital, London SE1, United Kingdon |
1982 | Institute of Clinical Medicine, University of Naples, Medical School II, Italy;, Department of Chemical Pathology and Metabolic Disorders, St. Thomas’ Hospital Medical School, London, England |
1980 | Clinica Medica, 2nd University Medical School, Naples, and Department of Chemical Pathology and Metabolic Disorders, St. Thomas’s Hospital Medical School, London |
1976 | Fellow American Association for the Advancement of Science, Reader in Biochemical Education, Courtauld Institute, Middlesex Hospital, London, University of London |
1974 | Department of Chemical Pathology, St Thomas's Hospital, London SE1 7EH, U.K |
1973 | Department of Clinical Chemistry, St. Thomas's Hospital, London S.E.1 Great Britain |
1972 | Departments of Clinical Chemistry, St. Thomas's Hospital, London S.E.1, and the Institute of Child Health, London WC1N1EH, U.K |
1969 | Fellow American Association for the Advancement of Science, Senior Lecturer in Biochemistry, Courtauld Institute, Middlesex Hospital, London, Recognised Teacher, University of London |
Concept | World rank |
---|---|
absorbed test sugars | #1 |
enhanced permeability week | #1 |
technique infant milk | #1 |
sodium sulphate absorption | #1 |
chapter 4 sources | #1 |
human intestinal permeability | #1 |
types 114 mmol | #1 |
sugars ileostomy | #1 |
mature pattern permeability | #1 |
lactulose absorbed | #1 |
continued infusion milks | #1 |
absorption rhamnose | #1 |
mucosa lactulose | #1 |
0001 lactulose | #1 |
xylose 3omethyldglucose | #1 |
ingested lactulose absorption | #1 |
birth temporary period | #1 |
increased permeability findings | #1 |
lactulose rhamnose | #1 |
lactuloserhamnose ratio | #1 |
intestinal isomaltase activity | #1 |
byin vitro estimation | #1 |
error chapter 4 | #1 |
permeability children | #1 |
increase 51credta recovery | #1 |
30methyldglucose | #1 |
mannitol intestinal uptake | #1 |
permeability neonatal bowel | #1 |
lactulose nonabsorbable sugars | #1 |
intestinal permeability absorption | #1 |
51credta markers | #1 |
impaired hydrolysis sucrose | #1 |
layer disaccharidases layer | #1 |
disaccharide excretion | #1 |
disaccharidases assessed | #1 |
recovery 51cr | #1 |
lrhamnose | #1 |
sugar probes | #1 |
permeability lactulose | #1 |
lactulose 51credta | #1 |
mammals immunological implications | #1 |
isomaltase inborn errors | #1 |
lrhamnose dxylose 3omethyld | #1 |
Sign-in to see all concepts, it's free! | |
Prominent publications by Ian S Menzies
Intestinal permeability in patients with Crohn's disease and their first degree relatives.
[ PUBLICATION ]
It has been reported that intestinal permeability to polyethylene glycol 400 is increased in patients with Crohn's disease and their apparently unaffected first degree relatives. Because of the implications that these findings have for the aetiology of Crohn's disease these studies were repeated. Patients with Crohn's disease (n = 28) and 32 first degree relatives from 11 families underwent a polyethylene glycol 400 (PEG400) intestinal permeability test and a hyperosmotic (1500 mosmol/l) ...
Known for Degree Relatives | Intestinal Permeability | Crohns Disease | Polyethylene Glycol | Patients Crohn |
Assessment of Intestinal Permeability and Absorption in Cirrhotic Patients with Ascites Using Combined Sugar Probes
[ PUBLICATION ]
Gastrointestinal dysfunction in patients with cirrhosis may contribute to complications such as malnutrition and spontaneous bacterial peritonitis. To determine whether cirrhotic patients with ascites have altered intestinal function, we compared intestinal permeability and absorption in patients with liver disease and normal subjects. Intestinal permeability and absorption were investigated in 66 cirrhotic patients (48 with ascites, 18 without ascites) and 74 healthy control subjects. ...
Known for Cirrhotic Patients | Intestinal Permeability | Sugar Probes | Liver Disease | Oral Administration |
BACKGROUND: The frequency with which non-steroidal anti-inflammatory drugs (NSAIDs) increase small intestinal permeability and cause inflammation is uncertain.
AIMS: To examine small intestinal permeability and inflammation in a large number of patients on long term NSAIDs.
METHODS: Sixty eight patients receiving six different NSAIDs for over six months underwent combined absorption-permeability tests at three different test dose osmolarities (iso-, hypo-, and hyperosmolar). Two hundred ...
Known for Intestinal Permeability | Patients Nsaids | Antiinflammatory Agents | Small Bowel | Steroidal Anti |
Comparison of Four Markers of Intestinal Permeability in Control Subjects and Patients with Coeliac Disease
[ PUBLICATION ]
BACKGROUND: Controversy surrounds the issue of intestinal permeability in patients with coeliac disease, polyethylene glycol 400 indicating reduced and di-/mono-saccharide urine excretion ratios and 51Cr-labeled ethylenediaminetetraacetic acid (EDTA) indicating increased permeability.
METHODS: We assessed the suitability of polyethylene glycol 400, L-rhamnose, lactulose, and 51Cr-EDTA as markers of intestinal permeability by assessing urine excretions after simultaneous intravenous ...
Known for Coeliac Disease | Intestinal Permeability | Polyethylene Glycol | Lactulose Rhamnose | 51cr Edta |
Increased small intestinal permeability caused by non-steroidal anti-inflammatory drugs (NSAIDs) is probably a prerequisite for NSAID enteropathy, a source of morbidity in patients with rheumatoid arthritis. This increased small intestinal permeability may be a summation of a local effect during drug absorption, a systemic effect after absorption, and a local effect of the drug excreted in bile, but the relative contribution made by these factors is unknown. We assessed the effect of ...
Known for Intestinal Permeability | Steroidal Anti | Drug Absorption | Nsaid Enteropathy | Rheumatoid Arthritis |
Comparison of enteral feeding and total parenteral nutrition after liver transplantation
[ PUBLICATION ]
Total parenteral nutrition is used for nutritional support in patients undergoing orthotopic liver transplantation but is associated with complications. We compared the efficacy and tolerability of early enteral feeding with total parenteral nutrition after liver transplantation. 24 patients were studied: 14 received enteral feeding and 10 total parenteral nutrition. A double-lumen enteral tube was used to deliver the feed directly into the jejunum with the second lumen of the tube being ...
Known for Enteral Feeding | Liver Transplantation | Nutrition Total | Intestinal Mucosal Integrity | Early Postoperative |
Effect of Iron Deficiency on Small Intestinal Permeability in Infants and Young Children
[ PUBLICATION ]
Small intestinal absorptive function can be disturbed in iron deficiency. We examined the permeability behavior of the small intestinal mucosa toward lactulose and rhamnose in 26 otherwise healthy children with iron deficiency. Their (mean +/- SD) age was 21 +/- 8.6 months; hemoglobin 7.9 +/- 0.9 g/dl, mean corpuscular volume (MCV) 60.1 +/- 3.4 fl, serum iron 2.72 +/- 0.66 mumol/L, serum ferritin 7.3 +/- 1.6 micrograms/L. After an isotonic oral load of both sugars, their 5-h urinary ...
Known for Iron Deficiency | Intestinal Permeability | Lactulose Rhamnose | Mucosa Intestine | Urinary Recovery |
Cardiopulmonary bypass impairs small intestinal transport and increases cut permeability
[ PUBLICATION ]
Gastrointestinal damage occurs in 0.6% to 2% of patients after cardiopulmonary bypass (CPB), and carries a mortality of 12% to 67%. The incidence of subclinical gastrointestinal damage may be much greater. We examined the effects of nonpulsatile, hypothermic CPB on intestinal absorption and permeability in 41 patients. Bowel mucosal saccharide transport and permeation were evaluated using 100 mL of an oral solution containing 3-O-methyl-D-glucose (0.2 g), D-xylose (0.5 g), L-rhamnose ...
Known for Cardiopulmonary Bypass | Patients Cpb | Small Intestinal | Lactulose Rhamnose | Aged Permeability |
Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea.
[ PUBLICATION ]
Intestinal function is poorly defined in patients with HIV infection. Absorptive capacity and intestinal permeability were assessed using 3-O-methyl-D-glucose, D-xylose, L-rhamnose, and lactulose in 88 HIV infected patients and the findings were correlated with the degree of immunosuppression (CD4 counts), diarrhoea, wasting, intestinal pathogen status, and histomorphometric analysis of jejunal biopsy samples. Malabsorption of 3-O-methyl-D-glucose and D-xylose was prevalent in all groups ...
Known for Intestinal Permeability | Absorptive Capacity | Hiv Patients | Coeliac Disease | Cd4 Lymphocyte |
Misoprostol reduces indomethacin-induced changes in human small intestinal permeability
[ PUBLICATION ]
This study examined whether indomethacin-induced increases in small intestinal permeability in man are prevented by concomitant administration of a prostaglandin analog (misoprostol). Twelve male volunteers were tested as baseline, following misoprostol alone (200 Μg, at −16, −12, −8.5, −4, −1.5, and +4 hr); following indomethacin alone (75 mg, at −8; 50 mg, −1 hr); and following coadministration of misoprostol and indomethacin as specified above. A 100-ml test solution containing ...
Known for Small Intestinal | Misoprostol Indomethacin | Paracellular Permeability | Male Volunteers | Rhamnose Xylose |
The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass
[ PUBLICATION ]
BACKGROUND/AIMS: Mean arterial pressure is reduced during hypothermic cardiopulmonary bypass. The aim of this study was to assess whether this was associated with intestinal hypoperfusion and whether it affected intestinal absorption and permeability.
METHODS: Twenty-six patients undergoing coronary artery bypass grafting underwent an intestinal absorption-permeability test involving ingestion of 3-O-methyl-D-glucose, D-xylose, L-rhamnose, and lactulose. Ingestion took place 2 days ...
Known for Intestinal Absorption | Cardiopulmonary Bypass | Arterial Pressure | Postoperative Day | Aged Permeability |
The Effect of Ingested Lactulose on Absorption of L-Rhamnose, D-Xylose, and 3-O-Methyl-D-Glucose in Subjects with Ileostomies
[ PUBLICATION ]
BACKGROUND: We have previously shown that small oral doses of poorly absorbed solute can significantly reduce absorption of test sugars in normal volunteers. To confirm these results and investigate the underlying mechanism, the effects of lactulose on absorption of three test sugars in subjects with ileostomies were studied.
METHODS: Ten fasted subjects with ileostomies ingested an isosmolar test solution containing 2.5 g 3-O-methyl-D-glucose, 5.0 g D-xylose, 1.0 g L-rhamnose, and 50 ...
Known for Test Solution | Rhamnose Xylose | Crohn Disease | 3 Methylglucose | Lactulose Male |
Nonsteroidal anti-inflammatory drug (NSAID)-induced increased intestinal permeability appears to be a prerequisite for NSAID enteropathy. It has been suggested that early metabolic events leading to the permeability changes may involve inhibition of glycolysis and the tricarboxylic acid cycle, in which case the coadministration of glucose and citrate (the substrates for these metabolic pathways) with indomethacin may afford some protection. The present study, using a combined intestinal ...
Known for Indomethacin Intestinal Permeability | Nsaid Enteropathy | Small Intestinal | Metabolic Pathways | Citric Acid |